Tationil Glutathione Injectable (Italy) Philippines

Please do note that no website, advertising, or opinion can replace consultation with an expert physician and before making any decision on using this product,

it is advisable to speak to your doctor first.

The information listed below is based on the leaflet (written in Italian language)

included in the box of Tationil.

 Some phrases may be translated incorrectly.

Please refer to the leaflet and discuss it with your doctor.

Tationil 600 mg/ 4 ml powder and solvent for solution for injection

Glutathione

Composition

1 Vial of powder for solution for injection contains:

Active substance: glutathione (sodium salt) 600 mg.

1 ampoule of solvent contains: water for injections 4 ml

Pharmaceutical Form and content

10 vials powder 600 mg + 10 ampoules 4 ml

Pharmacotherapeutic group

Antidote

Name and address of marketing authorization holder

Teofarma S. r.l. Via F. lli Cervi, 8- 27010 Valley Salimbebe (PV)

Name and address of the manufacturer

Vials powder:

Product is controlled by Alfa Wasserman s.p.a.

Via Enrico Fermi, 1 - 65020 Alanno (PE)

Solvent ampoules:

Product is controlled by Teofarma S.r.l. Viale Certosa 8/A- 27100 Pavia

Packaging and batch release:

Teofarma S.r.l. Viale Certosa 8/A- 27100 Pavia

Therapeutic Indications

Prophylaxis of neuropathy resulting from chemotherapy in combination with cisplatin or similar (Used in prophylaxis of neuropathy subsequent to chemotherapy treatment caused by ionogenic radiations or analogous.)

CONTRAINDICATIONS

Hypersensitivity to the product.

Precautions for use

None

Interactions

None

Pregnancy and breast-feeding

It is not recommended to use during pregnancy and lactation

Effects on driving, on the use of machinery

None

Dose, the method and time of administration

1-2 vials per day intramuscularly, intravenously slow or added to a drip or second different prescription (or following a doctor’s prescription)

Overdose

There are no known cases of overdose

Side effects

Rashes may occur very rarely that disappear by suspending the therapy

If any side effects not mentioned in this leaflet are noticed, it is recommended that you consult/inform your doctor

Do not use the medicinal product after the shelf life indicated on the external pack. The expiry date refers to the product in integral packaging and correctly stored.

Date of revision of the package leaflet by the Italian Agency of Drug

June 2010

Keep the product out of the reach and sight of children

TEOFARMA srl

Fax 0382.525845

Email: servizioclienti@teofarma.it